Constitutive Tyrosine Phosphorylation of ErbB-2 via Jak2 by Autocrine Secretion of Prolactin in Human Breast Cancer
Open Access
- 1 October 2000
- journal article
- Published by Elsevier
- Vol. 275 (43), 33937-33944
- https://doi.org/10.1074/jbc.m000743200
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Treatment of Breast CancerNew England Journal of Medicine, 1998
- Activation of the prolactin receptor but not the growth hormone receptor is important for induction of mammary tumors in transgenic mice.Journal of Clinical Investigation, 1997
- JAK2 Is Essential for Activation of c-fos and c-myc Promoters and Cell Proliferation through the Human Granulocyte-Macrophage Colony-stimulating Factor Receptor in BA/F3 CellsPublished by Elsevier ,1996
- Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitorNature, 1996
- c‐erbB‐2 anti‐sense phosphorothioate oligodeoxynucleotides inhibit growth and serum‐induced cell spreading of p185c‐erbB‐2‐overexpressing ovarian carcinoma cellsInternational Journal of Cancer, 1995
- Regulation of Ras-mediated signalling: more than one way to skin a catTrends in Biochemical Sciences, 1995
- Signal transduction by receptors with tyrosine kinase activityCell, 1990
- A Mr=190,000 glycoprotein phosphorylated on tyrosine residues in epidermal growth factor stimulated KB cells is the product of the C-erbB-2 geneBiochemical and Biophysical Research Communications, 1987
- Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu OncogeneScience, 1987
- Tyrosine Kinase Receptor with Extensive Homology to EGF Receptor Shares Chromosomal Location with neu OncogeneScience, 1985